|
JOSD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.912600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.378200E-01 |
| Normal-vs-Stage2 |
2.355700E-02 |
| Normal-vs-Stage3 |
7.982400E-02 |
| Normal-vs-Stage4 |
7.064600E-01 |
| Stage1-vs-Stage2 |
4.675700E-03 |
| Stage1-vs-Stage3 |
1.826400E-01 |
| Stage1-vs-Stage4 |
4.641000E-01 |
| Stage2-vs-Stage3 |
6.055400E-03 |
| Stage2-vs-Stage4 |
5.237800E-01 |
| Stage3-vs-Stage4 |
1.907760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.400800E-01 |
| Normal-vs-AfricanAmerican |
3.743200E-01 |
| Normal-vs-Asian |
4.740600E-01 |
| Caucasian-vs-AfricanAmerican |
4.709000E-01 |
| Caucasian-vs-Asian |
4.982000E-01 |
| AfricanAmerican-vs-Asian |
3.912000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.298200E-01 |
| Normal-vs-Female |
3.530300E-02 |
| Male-vs-Female |
2.221900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.944300E-02 |
| Normal-vs-Extreme_Weight |
6.350600E-01 |
| Normal-vs-Obese |
3.664000E-01 |
| Normal-vs-Extreme_Obese |
2.930200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.636400E-02 |
| Normal_Weight-vs-Obese |
2.266000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.100400E-02 |
| Extreme_Weight-vs-Obese |
5.985000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.561200E-01 |
| Obese-vs-Extreme_Obese |
1.554020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.978400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.225000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.858600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.385000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.970200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.023800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.924000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.364800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.948000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.207200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.440400E-01 |
| Normal-VS-Type2 PRCC |
3.534400E-01 |
| Normal-VS-KIRP CIMP |
1.310400E-02 |
| Normal-VS-Unclassified PRCC |
1.536950E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.479000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.536000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.097010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.986000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.575400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.773600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.262400E-01 |
| Normal-vs-N1 |
3.981000E-01 |
| Normal-vs-N2 |
8.319800E-01 |
| N0-vs-N1 |
6.315000E-01 |
| N0-vs-N2 |
9.535400E-01 |
| N1-vs-N2 |
7.882400E-01 |
|
|
